Interferon-gamma release assays versus tuberculin skin testing for the diagnosis of latent tuberculosis infection: An overview of the evidence

Pulmonary Medicine

Volumn , Issue , 2013, Pages

  Trajman, A ^a,b   Steffen, R E ^c   Menzies, D ^b  

^a GAMA FILHO UNIVERSITY   (Brazil)

^b MCGILL UNIVERSITY   (Canada)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; ISONIAZID; RIFAMPICIN;

BCG VACCINATION; COHORT ANALYSIS; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION; TUBERCULIN TEST;

EID: 84876511204     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2013/601737     Document Type: Review

References (142)

1. Organization World Health, Global Tuberculosis Control: WHO Report 2011 2011 Geneva, Switzerland World Health Organization
2. Dye C., Watt C. J., Bleed D. M., Hosseini S. M., Raviglione M. C., Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. Journal of the American Medical Association 2005 293 22 2767 2775 2-s2.0-20144370344 10.1001/jama.293.22.2767 (Pubitemid 40965089)
3. Dye C., Williams B. G., Eliminating human tuberculosis in the twenty-first century. Journal of the Royal Society Interface 2008 5 23 653 662 2-s2.0-42549162084 10.1098/rsif.2007.1138 (Pubitemid 351589747)
4. Huebner R. E., Schein M. F., Bass J. B., The tuberculin skin test. Clinical Infectious Diseases 1993 17 6 968 975 2-s2.0-0027374605 (Pubitemid 23358739)
5. Pesanti E. L., The negative tuberculin test: tuberculin, HIV, and anergy panels. American Journal of Respiratory and Critical Care Medicine 1994 149 6 1699 1709 2-s2.0-0028200648 (Pubitemid 24175999)
6. Huebner R. E., Villarino M. E., Snider D. E., Tuberculin skin testing and the HIV epidemic. Journal of the American Medical Association 1992 267 3 409 410 2-s2.0-0026531010 10.1001/jama.267.3.409
7. Farhat M., Greenaway C., Pai M., Menzies D., False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? International Journal of Tuberculosis and Lung Disease 2006 10 11 1192 1204 2-s2.0-33750796878 (Pubitemid 44713473)
8. Diel R., Nienhaus A., Lange C., Schaberg T., Cost-optimisation of screening for latent tuberculosis in close contacts. European Respiratory Journal 2006 28 1 35 44 2-s2.0-33745177672 10.1183/09031936.06.00011806 (Pubitemid 44914258)
9. Bearman J. E., Kleinman H., Glyer V. V., Lacroix O. M., A study of variability in tuberculin test reading. American Review of Respiratory Disease 1964 90 913 919
10. Chaparas S. D., Vandiviere H. M., Melvin I., Tuberculin test. Variability with the Mantoux procedure. American Review of Respiratory Disease 1985 132 1 175 177 2-s2.0-0022262639 (Pubitemid 15026209)
11. Perez-Stable E., Slutkin G., A demonstration of lack of variability among six tuberculin skin test readers. American Journal of Public Health 1985 75 11 1341 1343 2-s2.0-0022405423 (Pubitemid 16245034)
12. Menzies D., Gardiner G., Farhat M., Greenaway C., Pai M., Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results. International Journal of Tuberculosis and Lung Disease 2008 12 5 498 505 2-s2.0-43949107191 (Pubitemid 351703056)
13. Vynnycky E., Fine P. E. M., The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiology and Infection 1997 119 2 183 201 2-s2.0-0030719950 10.1017/S0950268897007917 (Pubitemid 27474799)
14. Grzybowski S., Allen E. A., The challenge of tuberculosis in decline. A study based on the epidemiology of tuberculosis in ontario, Canada. The American Review of Respiratory Disease 1964 90 707 720 2-s2.0-0001328733
15. Menzies D., Interpretation of repeated tuberculin tests: boosting, conversion, and reversion. American Journal of Respiratory and Critical Care Medicine 1999 159 1 15 21 2-s2.0-0032902382 (Pubitemid 29036497)
16. Bass J. B. Jr., Serio R. A., The use of repeat skin tests to eliminate the booster phenomenon in serial tuberculin testing. American Review of Respiratory Disease 1981 123 4 394 396 2-s2.0-0019491461 (Pubitemid 11105705)
17. Menzies D., Al Jahdali H., Al Otaibi B., Recent developments in treatment of latent tuberculosis infection. Indian Journal of Medical Research 2011 133 3 257 266 2-s2.0-79952967246
18. Metcalfe J. Z., Everett C. K., Steingart K. R., Cattamanchi A., Huang L., Hopewell P. C., Interferon- γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. Journal of Infectious Diseases 2011 204, supplement 4 S1120 S1129
19. Bucher H. C., Griffith L. E., Guyatt G. H., Sudre P., Naef M., Sendi P., Battegay M., Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS 1999 13 4 501 507 2-s2.0-0033545450
20. Samandari T., Agizew T. B., Nyirenda S., Tedla Z., Sibanda T., Shang N., Mosimaneotsile B., Motsamai O. I., Bozeman L., Davis M. K., Talbot E. A., Moeti T. L., Moffat H. J., Kilmarx P. H., Castro K. G., Wells C. D., 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. The Lancet 2011 377 9777 1588 1598 2-s2.0-79955694277 10.1016/S0140-6736(11)60204-3
21. Andersen P., Munk M. E., Pollock J. M., Doherty T. M., Specific immune-based diagnosis of tuberculosis. The Lancet 2000 356 9235 1099 1104 2-s2.0-0034706231
22. Pai M., Zwerling A., Menzies D., Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Annals of Internal Medicine 2008 149 3 177 184 2-s2.0-48749127991
23. Pai M., Joshi R., Dogra S., Zwerling A. A., Gajalakshmi D., Goswami K., Reddy M. V. R., Kalantri S., Hill P. C., Menzies D., Hopewell P. C., T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. International Journal of Tuberculosis and Lung Disease 2009 13 1 84 92 2-s2.0-58149376166
24. Dheda K., Van Zyl-Smit R. N., Sechi L. A., Badri M., Meldau R., Meldau S., Symons G., Semple P. L., Maredza A., Dawson R., Wainwright H., Whitelaw A., Vallie Y., Raubenheimer P., Bateman E. D., Zumla A., Utility of quantitative T-cell responses versus unstimulated interferon- γ for the diagnosis of pleural tuberculosis. European Respiratory Journal 2009 34 5 1118 1126 2-s2.0-71049122455 10.1183/09031936.00005309
25. Detjen A. K., Loebenberg L., Grewal H. M. S., Stanley K., Gutschmidt A., Kruger C., Du Plessis N., Kidd M., Beyers N., Walzl G., Hesseling A. C., Short-term reproducibility of a commercial interferon gamma release assay. Clinical and Vaccine Immunology 2009 16 8 1170 1175 2-s2.0-68149172586 10.1128/CVI.00168-09
26. Doberne D., Gaur R. L., Banaei N., Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection. Journal of Clinical Microbiology 2011 49 8 3061 3064 2-s2.0-79960952611 10.1128/JCM.01136-11
27. Ringshausen F. C., Nienhaus A., Torres Costa J., Knoop H., Schlosser S., Schultze-Werninghaus G., Within-subject variability of Mycobacterium tuberculosis -specific gamma interferon responses in German health care workers. Clinical and Vaccine Immunology 2011 18 7 1176 1182
28. Slater M., Parsonnet J., Banaei N., Investigation of false-positive results given by the QuantiFERON-TB gold in-tube assay. Journal of Clinical Microbiology 2012 50 9 3105 3107
29. Pai M., O'Brien R., Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Medicine 2007 4 6 e208 2-s2.0-34347269232 10.1371/journal.pmed.0040208 (Pubitemid 46998611)
30. Diel R., Loddenkemper R., Nienhaus A., Predictive value of interferon-gamma release assays and tuberculin skin testing for predicting progression from latent TB infection to disease state: a meta-analysis. Chest 2012 142 1 63 75 10.1378/chest.11-3157
31. Rangaka M. X., Wilkinson K. A., Glynn J. R., Ling D., Menzies D., Mwansa-Kambafwile J., Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. The Lancet Infectious Diseases 2012 12 1 45 55
32. Denkinger C. M., Dheda K., Pai M., Guidelines on interferon- γ release assays for tuberculosis infection: concordance, discordance or confusion? Clinical Microbiology and Infection 2011 17 6 806 814 2-s2.0-79959291025 10.1111/j.1469-0691.2011.03555.x
33. Organization World Health, Use of Tuberculosis Interferon-Gamma Release Assays (IGRAs) in Low- and Middle-Income Countries: Policy Statement 2011 Geneva, Switzerland World Health Organization
34. Tsiouris S. J., Coetzee D., Toro P. L., Austin J., Stein Z., El-Sadr W., Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. Journal of Clinical Microbiology 2006 44 8 2844 2850 2-s2.0-33747190099 10.1128/JCM.02411-05 (Pubitemid 44228579)
35. Kobashi Y., Mouri K., Yagi S., Obase Y., Fukuda M., Miyashita N., Oka M., Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis. Internal Medicine 2008 47 4 237 243 2-s2.0-40749144795 10.2169/internalmedicine.47.0389 (Pubitemid 351377284)
36. Zwerling A., Behr M. A., Verma A., Brewer T. F., Menzies D., Pai M., The BCG world atlas: a database of global BCG vaccination policies and practices. PLoS Medicine 2011 8 3 2-s2.0-79953726311 10.1371/journal.pmed.1001012 e1001012
37. Chun J. K., Kim C. K., Kim H. S., Jung G. Y., Lee T. J., Kim K. H., Kim D. S., The role of a whole blood interferon- γ assay for the detection of latent tuberculosis infection in Bacille Calmette-Guérin vaccinated children. Diagnostic Microbiology and Infectious Disease 2008 62 4 389 394 2-s2.0-56049088290 10.1016/j.diagmicrobio.2008.08.022
38. Bianchi L., Galli L., Moriondo M., Veneruso G., Becciolini L., Azzari C., Chiappini E., De Martino M., Interferon-gamma release assay improves the diagnosis of tuberculosis in children. Pediatric Infectious Disease Journal 2009 28 6 510 514 2-s2.0-67649515861 10.1097/INF.0b013e31819abf6b
39. Hansted E., Andriuskeviciene A., Sakalauskas R., Kevalas R., Sitkauskiene B., T-cell-based diagnosis of tuberculosis infection in children in Lithuania: a country of high incidence despite a high coverage with bacille Calmette-Guerin vaccination. BMC Pulmonary Medicine 2009 9, article 41 2-s2.0-69949151391 10.1186/1471-2466-9-41
40. Hesseling A. C., Mandalakas A. M., Kirchner H. L., Chegou N. N., Marais B. J., Stanley K., Zhu X., Black G., Beyers N., Walzl G., Highly discordant T cell responses in individuals with recent exposure to household tuberculosis. Thorax 2009 64 10 840 846 2-s2.0-70349664470 10.1136/thx.2007.085340
41. Higuchi K., Kawabe Y., Mitarai S., Yoshiyama T., Harada N., Mori T., Comparison of performance in two diagnostic methods for tuberculosis infection. Medical Microbiology and Immunology 2009 198 1 33 37 2-s2.0-58549112377 10.1007/s00430-008-0102-5
42. Lighter J., Rigaud M., Eduardo R., Peng C. H., Pollack H., Latent tuberculosis diagnosis in children by using the QuantiFERON-TB gold in-tube test. Pediatrics 2009 123 1 30 37 2-s2.0-59449102430 10.1542/peds.2007-3618
43. Lucas M., Nicol P., McKinnon E., Whidborne R., Lucas A., Thambiran A., Burgner D., Waring J., French M., A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children. Thorax 2010 65 5 442 448 2-s2.0-77951990998 10.1136/thx.2009.127555
44. Stefan D. C., Dippenaar A., Detjen A. K., Schaaf H. S., Marais B. J., Kriel B., Loebenberg L., Walzl G., Hesseling A. C., Interferon-gamma release assays for the detection of Mycobacterium tuberculosis infection in children with cancer. International Journal of Tuberculosis and Lung Disease 2010 14 6 689 694 2-s2.0-77952412064
45. Mandalakas A. M., Hesseling A. C., Chegou N. N., Kirchner H. L., Zhu X., Marais B. J., Black G. F., Beyers N., Walzl G., High level of discordant IGRA results in HIV-infected adults and children. International Journal of Tuberculosis and Lung Disease 2008 12 4 417 423 2-s2.0-41949113459 (Pubitemid 351507255)
46. Domínguez J., Ruiz-Manzano J., De Souza-Galvão M., Latorre I., Milà C., Blanco S., Jiménez M. Á., Prat C., Lacoma A., Altet N., Ausina V., Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis. Clinical and Vaccine Immunology 2008 15 1 168 171 2-s2.0-43149119506 10.1128/CVI.00364-07 (Pubitemid 351966546)
47. Mandalakas A. M., Detjen A. K., Hesseling A. C., Benedetti A., Menzies D., Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. International Journal of Tuberculosis and Lung Disease 2011 15 8 1018 1032 2-s2.0-79959309217 10.5588/ijtld.10.0631
48. Bakir M., Millington K. A., Soysal A., Deeks J. J., Efee S., Aslan Y., Dosanjh D. P. S., Lalvani A., Prognostic value of a T-cell-based, interferon- γ biomarker in children with tuberculosis contact. Annals of Internal Medicine 2008 149 11 777 786 2-s2.0-57349149604
49. del Corral H., Paris S. C., Marin N. D., Marin D. M., Lopez L., Henao H. M., IFNgamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia. PLoS ONE 2009 4 12 e8257
50. Hill P. C., Jackson-Sillah D. J., Fox A., Brookes R. H., de Jong B. C., Lugos M. D., Adetifa I. M., Donkor S. A., Aiken A. M., Howie S. R., Corrah T., McAdam K. P., Adegbola R. A., Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS ONE 2008 3 1 2-s2.0-38949215722 10.1371/journal.pone.0001379 e1379 (Pubitemid 351223138)
51. Kik S. V., Franken W. P. J., Mensen M., Cobelens F. G. J., Kamphorst M., Arend S. M., Erkens C., Gebhard A., Borgdorff M. W., Verver S., Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. European Respiratory Journal 2010 35 6 1346 1353 2-s2.0-77953519650 10.1183/09031936. 00098509
52. Cattamanchi A., Smith R., Steingart K. R., Metcalfe J. Z., Date A., Coleman C., Marston B. J., Huang L., Hopewell P. C., Pai M., Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes 2011 56 3 230 238 2-s2.0-79951811907 10.1097/QAI.0b013e31820b07ab
53. Zwerling A., van den Hof S., Scholten J., Cobelens F., Menzies D., Pai M., Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 2011 67 1 62 70 10.1136/thx.2010.143180
54. Aichelburg M. C., Rieger A., Breitenecker F., Pfistershammer K., Tittes J., Eltz S., Aichelburg A. C., Stingl G., Makristathis A., Kohrgruber N., Detection and prediction of active tuberculosis disease by a whole-blood interferon- γ release assay in HIV-l-infected individuals. Clinical Infectious Diseases 2009 48 7 954 962 2-s2.0-63649149534 10.1086/597351
55. Clark S. A., Martin S. L., Pozniak A., Steel A., Ward B., Dunning J., Henderson D. C., Nelson M., Gazzard B., Kelleher P., Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clinical and Experimental Immunology 2007 150 2 238 244 2-s2.0-35348934353 10.1111/j.1365-2249.2007.03477.x (Pubitemid 47609557)
56. Jonnalagadda S., Payne B. L., Brown E., Wamalwa D., Obimbo E. M., Majiwa M., Farquhar C., Otieno P., Mbori-Ngacha D., John-Stewart G., Latent tuberculosis detection by interferon γ release assay during pregnancy predicts active tuberculosis and mortality in human immunodeficiency virus type 1-infected women and their children. Journal of Infectious Diseases 2010 202 12 1826 1835 2-s2.0-78650399617 10.1086/657411
57. Santin M., Casas S., Saumoy M., Andreu A., Moure R., Alcaide F., Ferrer E., Podzamczer D., Detection of latent tuberculosis by the tuberculin skin test and a whole-blood interferon- γ release assay, and the development of active tuberculosis in HIV-seropositive persons. Diagnostic Microbiology and Infectious Disease 2011 69 1 59 65 2-s2.0-78649930114 10.1016/j.diagmicrobio. 2010.09.005
58. Zhang L. F., Liu X. Q., Zuo L. Y., Li T. S., Deng G. H., Wang A. X., Longitudinal observation of an interferon gamma-released assay (T-SPOT.TB) for Mycobacterium tuberculosis infection in AIDS patients on highly active antiretroviral therapy. Chinese Medical Journal 2010 123 9 1117 1121 2-s2.0-77952382103 10.3760/cma.j.issn.0366-6999.2010.09.003
59. Akolo C., Adetifa I., Shepperd S., Volmink J., Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database of Systematic Reviews 2010 1 CD000171 2-s2.0-77950913100
60. Dowdy D. W., Golub J. E., Tests for latent tuberculosis infection and isoniazid preventive therapy. The Lancet Infectious Diseases 2012 12 11 827 828
61. Ribeiro S., Dooley K., Hackman J., Loredo C., Efron A., Chaisson R. E., Conde M. B., Boechat N., Dorman S. E., T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infectious Diseases 2009 9, article 23 2-s2.0-62349129135 10.1186/1471-2334-9-23
62. Bosshard V., Roux-Lombard P., Perneger T., Metzger M., Vivien R., Rochat T., Janssens J. P., Do results of the T-SPOT.TB interferon- γ release assay change after treatment of tuberculosis? Respiratory Medicine 2009 103 1 30 34 2-s2.0-57949110978 10.1016/j.rmed.2008.09.012
63. Chee C. B., KhinMar K. W., Gan S. H., Barkham T. M., Koh C. K., Shen L., Tuberculosis treatment effect on T-cell interferon-gamma responses to Mycobacterium tuberculosis -specific antigens. European Respiratory Journal 2010 36 2 355 361
64. Latorre I., Altet N., de Souza-Galvao M., Ruiz-Manzano J., Lacoma A., Prat C., Specific Mycobacterium tuberculosis T cell responses to RD1-selected peptides for the monitoring of anti-tuberculosis therapy. Scandinavian Journal of Infectious Diseases 2012 44 3 161 167
65. Domínguez J., Souza-Galvão M. D., Ruiz-Manzano J., Latorre I., Prat C., Lacoma A., Milà C., Jiménez M. Á., Blanco S., Maldonado J., Altet N., Ausina V., T-cell responses to the Mycobacterium tuberculosis -specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment. Diagnostic Microbiology and Infectious Disease 2009 63 1 43 51 2-s2.0-57349164065 10.1016/j. diagmicrobio.2008.09.010
66. Dheda K., Pooran A., Pai M., Miller R. F., Lesley K., Booth H. L., Scott G. M., Akbar A. N., Zumla A., Rook G. A., Interpretation of Mycobacterium tuberculosis antigen-specific IFN- γ release assays (T-SPOT.TB) and factors that may modulate test results. Journal of Infection 2007 55 2 169 173 2-s2.0-34447093772 10.1016/j.jinf.2007.02.005 (Pubitemid 47029747)
67. Franken W. P. J., Arend S. M., Thijsen S. F. T., Bouwman J. J. M., Koster B. F. P. J., Van Dissel J. T., Bossink A. W. J., Interferon-gamma release assays during follow-up of tuberculin skin test-positive contacts. International Journal of Tuberculosis and Lung Disease 2008 12 11 1286 1294 2-s2.0-56249101371
68. Sauzullo I., Mengoni F., Lichtner M., Massetti A. P., Rossi R., Iannetta M., Marocco R., Del Borgo C., Soscia F., Vullo V., Mastroianni C. M., In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon- γ T cell response. PLoS ONE 2009 4 4 2-s2.0-65249095474 10.1371/journal.pone.0005187 e5187
69. Kobashi Y., Sugiu T., Ohue Y., Mouri K., Obase Y., Miyashita N., Oka M., Long-term follow-up of the QuantiFERON TB-2G test for active tuberculosis disease. Internal Medicine 2008 47 22 1957 1961 2-s2.0-59949088334 10.2169/internalmedicine.47.1313
70. Goletti D., Parracino M. P., Butera O., Bizzoni F., Casetti R., Dainotto D., Anzidei G., Nisii C., Ippolito G., Poccia F., Girardi E., Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study. Respiratory Research 2007 8, article 5 2-s2.0-34447502983 10.1186/1465-9921-8-5
71. Dyrhol-Riise A. M., Gran G., Wenzel-Larsen T., Blomberg B., Haanshuus C. G., Mørkve O., Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country. BMC Infectious Diseases 2010 10, article 57 2-s2.0-77951242451 10.1186/1471-2334-10-57
72. Lee S. H., Lew W. J., Kim H. J., Lee H. K., Lee Y. M., Cho C. H., Lee E. J., Lee D. Y., Ryu S. W., Oh S. Y., Kim S. O., Shim T. S., Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak. Respiratory Medicine 2010 104 3 448 453 2-s2.0-76549135610 10.1016/j.rmed.2009.10.006
73. Lee S. W., Lee C. T., Yim J. J., Serial interferon-gamma release assays during treatment of active tuberculosis in young adults. BMC Infectious Diseases 2010 10, article 300 2-s2.0-77957913934 10.1186/1471-2334-10-300
74. Bocchino M., Chairadonna P., Matarese A., Bruzzese D., Salvatores M., Tronci M., Moscariello E., Galati D., Alma M. G., Sanduzzi A., Altieri A. M., Limited usefulness of QuantiFERON-TB GOLD in-tube for monitoring anti-tuberculosis therapy. Respiratory Medicine 2010 104 10 1551 1556 2-s2.0-77956343411 10.1016/j.rmed.2010.05.011
75. Herrmann J. L., Belloy M., Porcher R., Simonney N., Aboutaam R., Lebourgeois M., Gaudelus J., De Losangeles L., Chadelat K., Scheinmann P., Beydon N., Fauroux B., Bingen M., Terki M., Barraud D., Cruaud P., Offredo C., Ferroni A., Berche P., Moissenet D., Vuthien H., Doit C., Bingen E., Lagrange P. H., Temporal dynamics of interferon gamma responses in children evaluated for tuberculosis. PLoS ONE 2009 4 1 e4130 2-s2.0-59249089073 10.1371/journal.pone. 0004130
76. Nenadic N., Kirin B. K., Letoja I. Z., Plavec D., Topic R. Z., Dodig S., Serial interferon-gamma release assay in children with latent tuberculosis infection and children with tuberculosis. Pediatric Pulmonology 2012 47 4 401 408
77. Chiappini E., Fossi F., Bonsignori F., Sollai S., Galli L., de Martino M., Utility of interferon-gamma release assay results to monitor anti-tubercular treatment in adults and children. Clinical Therapeutics 2012 34 5 1041 1048
78. Bamford A. R. J., Crook A. M., Clark J. E., Zohreh N., Dixon G., Paton J. Y., Riddell A., Drobniewski F., Riordan A., Anderson S. T., Williams A., Walters S., Kampmann B., Comparison of interferon- γ release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study. Archives of Disease in Childhood 2010 95 3 180 186 2-s2.0-77949889955 10.1136/adc.2009.169805
79. Connell T. G., Davies M. A., Johannisen C., Wood K., Pienaar S., Wilkinson K. A., Wilkinson R. J., Zar H. J., Beatty D., Nicol M. P., Curtis N., Eley B., Reversion and conversion of Mycobacterium tuberculosis IFN- γ ELISpot results during anti-tuberculous treatment in HIV-infected children. BMC Infectious Diseases 2010 10, article 138 2-s2.0-77952710912 10.1186/1471-2334- 10-138
80. Kampmann B., Whittaker E., Williams A., Walters S., Gordon A., Martinez-Alier N., Williams B., Crook A. M., Hutton A. M., Anderson S. T., Interferon- γ release assays do not identify more children with active tuberculosis than the tuberculin skin test. European Respiratory Journal 2009 33 6 1374 1382 2-s2.0-69249093827 10.1183/09031936.00153408
81. Lewinsohn D. A., Lobato M. N., Jereb J. A., Interferon- γ release assays: new diagnostic tests for Mycobacterium tuberculosis infection, and their use in children. Current Opinion in Pediatrics 2010 22 1 71 76 2-s2.0-75749112161 10.1097/MOP.0b013e3283350301
82. MacHingaidze S., Wiysonge C. S., Gonzalez-Angulo Y., Hatherill M., Moyo S., Hanekom W., Mahomed H., The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatric Infectious Disease Journal 2011 30 8 694 700 2-s2.0-79959285515 10.1097/INF.0b013e318214b915
83. Nenadic N., Kirin B. K., Letoja I. Z., Plavec D., Topic R. Z., Dodig S., Serial interferon- γ release assay in children with latent tuberculosis infection and children with tuberculosis. Pediatric Pulmonology 2012 47 4 401 408
84. Nicol M. P., Davies M. A., Wood K., Hatherill M., Workman L., Hawkridge A., Eley B., Wilkinson K. A., Wilkinson R. J., Hanekom W. A., Beatty D., Hussey G., Comparison of T-SPOT. TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics 2009 123 1 38 43 2-s2.0-59449110080 10.1542/peds.2008-0611
85. Aabye M. G., Ravn P., PrayGod G., Jeremiah K., Mugomela A., Jepsen M., Faurholt D., Range N., Friis H., Changalucha J., Andersen A. B., The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS ONE 2009 4 1 2-s2.0-64149108534 10.1371/journal.pone.0004220 e4220
86. Adetifa I. M. O., Lugos M. D., Hammond A., Jeffries D., Donkor S., Adegbola R. A., Hill P. C., Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. BMC Infectious Diseases 2007 7, article 122 2-s2.0-38749150016 10.1186/1471-2334-7-122 (Pubitemid 351176443)
87. Adetifa I. M. O., Ota M. O. C., Jeffries D. J., Hammond A., Lugos M. D., Donkor S., Patrick O., Adegbola R. A., Hill P. C., Commercial interferon gamma release assays compared to the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection in childhood contacts in the gambia. Pediatric Infectious Disease Journal 2010 29 5 439 443 2-s2.0-77951824316 10.1097/INF.0b013e3181cb45da
88. Baba K., Sørnes S., Hoosen A. A., Lekabe J. M., Mpe M. J., Langeland N., Dyrhol-Riise A. M., Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON TB-Gold interferon-gamma assay. BMC Infectious Diseases 2008 8, article 35 2-s2.0-42049090766 10.1186/1471-2334-8-35 (Pubitemid 351516591)
89. Brock I., Ruhwald M., Lundgren B., Westh H., Mathiesen L. R., Ravn P., Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon- γ test. Respiratory Research 2006 7, article 56 2-s2.0-33746554487 10.1186/1465-9921-7-56 (Pubitemid 44131691)
90. Cattamanchi A., Ssewenyana I., Davis J. L., Huang L., Worodria W., den Boon S., Yoo S., Andama A., Hopewell P. C., Cao H., Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection. BMC Infectious Diseases 2010 10, article 75 2-s2.0-77951182439 10.1186/1471-2334-10-75
91. Dheda K., Lalvani A., Miller R. F., Scott G., Booth H., Johnson M. A., Zumla A., Rook G. A. W., Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS 2005 19 17 2038 2041 2-s2.0-27944511070 (Pubitemid 41669032)
92. Dheda K., Van Zyl Smit R., Badri M., Pai M., T-cell interferon- γ release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Current Opinion in Pulmonary Medicine 2009 15 3 188 200 2-s2.0-67649227784 10.1097/MCP.0b013e32832a0adc
93. Dheda K., van Zyl-Smit R. N., Meldau R., Meldau S., Symons G., Khalfey H., Govender N., Rosu V., Sechi L. A., Maredza A., Semple P., Whitelaw A., Wainwright H., Badri M., Dawson R., Bateman E. D., Zumla A., Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis. Thorax 2009 64 10 847 853 2-s2.0-70349669293 10.1136/thx.2009.116376
94. Garfein R. S., Lozada R., Liu L., Laniado-Laborin R., Rodwell T. C., Deiss R., Alvelais J., Catanzaro A., Chiles P. G., Strathdee S. A., High prevalence of latent tuberculosis infection among injection drug users in Tijuana, Mexico. International Journal of Tuberculosis and Lung Disease 2009 13 5 626 632 2-s2.0-67649519452
95. Jiang W., Shao L., Zhang Y., Zhang S., Meng C., Xu Y., Huang L., Wang Y., Wang Y., Weng X., Zhang W., High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN- γ release assay among HIV-infected individuals in BCG-vaccinated area. BMC Immunology 2009 10, article 31 2-s2.0-67649853308 10.1186/1471-2172-10-31
96. Lee S. S. J., Liu Y. C., Huang T. S., Chen Y. S., Tsai H. C., Wann S. R., Lin H. H., Comparison of the interferon-gamma; release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers. Scandinavian Journal of Infectious Diseases 2008 40 5 373 380 2-s2.0-42549155422 10.1080/00365540701730743 (Pubitemid 351575072)
97. Machado A. Jr., Emodi K., Takenami I., Finkmoore B. C., Barbosa T., Carvalho J., Cavalcanti L., Santos G., Tavares M., Mota M., Barreto F., Reis M. G., Arruda S., Riley L. W., Analysis of discordance between the tuberculin skin test and the interferon-gamma release assay. International Journal of Tuberculosis and Lung Disease 2009 13 4 446 453 2-s2.0-64549103817
98. Rangaka M. X., Wilkinson K. A., Seldon R., Van Cutsem G., Meintjes G. A., Morroni C., Mouton P., Diwakar L., Connell T. G., Maartens G., Wilkinson R. J., Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection. American Journal of Respiratory and Critical Care Medicine 2007 175 5 514 520 2-s2.0-33847608011 10.1164/rccm.200610-1439OC (Pubitemid 46354256)
99. Richeldi L., Losi M., D'Amico R., Luppi M., Ferrari A., Mussini C., Codeluppi M., Cocchi S., Prati F., Paci V., Meacci M., Meccugni B., Rumpianesi F., Roversi P., Cerri S., Luppi F., Ferrara G., Latorre I., Gerunda G. E., Torelli G., Esposito R., Fabbri L. M., Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest 2009 136 1 198 204 2-s2.0-67649807103 10.1378/chest.08-2575
100. Rivas I., Latorre I., Sanvisens A., Domínguez J., Tor J., Prat C., Rey-Joly C., Muga R., Prospective evaluation of latent tuberculosis with interferon- γ release assays in drug and alcohol abusers. Epidemiology and Infection 2009 137 9 1342 1347 2-s2.0-69949120168 10.1017/S0950268809002131
101. Ruhwald M., Petersen J., Kofoed K., Nakaoka H., Cuevas L. E., Lawson L., Squire S. B., Eugen-Olsen J., Ravn P., Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS ONE 2008 3 8 2-s2.0-51349105327 10.1371/journal.pone.0002858 e2858
102. Stephan C., Wolf T., Goetsch U., Bellinger O., Nisius G., Oremek G., Rakus Z., Gottschalk R., Stark S., Brodt H. R., Staszewski S., Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS 2008 22 18 2471 2479 2-s2.0-57349168026 10.1097/QAD.0b013e3283188415
103. Talati N. J., Seybold U., Humphrey B., Aina A., Tapia J., Weinfurter P., Albalak R., Blumberg H. M., Poor concordance between interferon- γ release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infectious Diseases 2009 9, article 15 2-s2.0-61749083640 10.1186/1471-2334-9-15
104. Chang B., Park H. Y., Jeon K., Ahn J. K., Cha H. S., Koh E. M., Interferon-gamma release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea. Clinical Rheumatology 2011 30 12 1535 1541
105. Tavast E., Tuuminen T., Pakkanen S. H., Eriksson M., Kantele A., Jarvinen A., Immunosuppression adversely affects TST but Not IGRAs in patients with psoriasis or inflammatory musculoskeletal diseases. International Journal of Rheumatology 2012 2012 8 381929 10.1155/2012/381929
106. Smith R., Cattamanchi A., Steingart K. R., Denkinger C., Dheda K., Winthrop K. L., Interferon-gamma release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders. Current Opinion in Rheumatology 2011 23 4 377 384
107. Ling D. I., Pai M., Davids V., Brunet L., Lenders L., Meldau R., Are interferon-gamma release assays useful for diagnosing active tuberculosis in a high-burden setting? European Respiratory Journal 2011 38 3 649 656
108. Chee C. B. E., Gan S. H., KhinMar K. W., Barkham T. M., Koh C. K., Liang S., Wang Y. T., Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis. Journal of Clinical Microbiology 2008 46 6 1935 1940 2-s2.0-45149112240 10.1128/JCM.02403-07 (Pubitemid 351831823)
109. + T-cells in HIV infection. European Respiratory Journal 2010 35 3 619 626 2-s2.0-77951184831 10.1183/09031936.00045509
110. Markova R., Todorova Y., Drenska R., Elenkov I., Yankova M., Stefanova D., Usefulness of interferon-gamma release assays in the diagnosis of tuberculosis infection in HIV-infected patients in Bulgaria. Biotechnology and Biotechnological Equipment 2009 23 1 1103 1108 2-s2.0-62749098719
111. Bartalesi F., Vicidomini S., Goletti D., Fiorelli C., Fiori G.,
112. Behar S. M., Shin D. S., Maier A., Coblyn J., Helfgott S., Weinblatt M. E., Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy. Journal of Rheumatology 2009 36 3 546 551 2-s2.0-65649093724 10.3899/jrheum.080854
113. Bocchino M., Matarese A., Bellofiore B., Giacomelli P., Santoro G., Balato N., Castiglione F., Scarpa R., Perna F., Signoriello G., Galati D., Ponticiello A., Sanduzzi A., Performance of two commercial blood IFN- γ release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF- treatment. European Journal of Clinical Microbiology and Infectious Diseases 2008 27 10 907 913 2-s2.0-53549089852 10.1007/s10096-008-0519-1
114. Cobanoglu N., Ozcelik U., Kalyoncu U., Ozen S., Kiraz S., Gurcan N., Kaplan M., Dogru D., Yalcin E., Pekcan S., Kose M., Topaloglu R., Besbas N., Bakkaloglu A., Kiper N., Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers. International Journal of Tuberculosis and Lung Disease 2007 11 11 1177 1182 2-s2.0-36348941822 (Pubitemid 350146297)
115. Gogus F., Günendi Z., Karakus R., Erdogan Z., Hizel K., Atalay F., Comparison of tuberculin skin test and QuantiFERON-TB gold in tube test in patients with chronic inflammatory diseases living in a tuberculosis endemic population. Clinical and Experimental Medicine 2010 10 3 173 177 2-s2.0-78049514198 10.1007/s10238-009-0082-9
116. Kleinert S., Kurzai O., Elias J., Marten K., Engelke C., Feuchtenberger M., Sandstede J., Frosch M., Tony H. P., Kneitz C., Comparison of two interferon- γ release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases. Annals of the Rheumatic Diseases 2010 69 4 782 784 2-s2.0-77950305965 10.1136/ard.2009. 113829
117. Kwakernaak A. J., Houtman P. M., Weel J. F. L., Spoorenberg J. P. L., Jansen T. L. T. A., A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor inhibitor. Clinical Rheumatology 2011 30 4 505 510 2-s2.0-79954431150 10.1007/s10067-010-1550-z
118. Laffitte E., Janssens J. P., Roux-Lombard P., Thielen A. M., Barde C., Marazza G., Panizzon R. G., Saurat J. H., Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon- γ release assay vs. tuberculin skin test. British Journal of Dermatology 2009 161 4 797 800 2-s2.0-70349326740 10.1111/j.1365-2133.2009. 09331.x
119. Marques C. D. L., Duarte A. L. B. P., De Lorena V. M. B., Souza J. R., Souza W. V., De Miranda Gomes Y., De Carvalho E. M. F., Evaluation of an interferon gamma assay in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis. Rheumatology International 2009 30 1 57 62 2-s2.0-71349083782 10.1007/s00296-009-0910-y
120. Martin J., Walsh C., Gibbs A., McDonnell T., Fearon U., Keane J., Codd M. B., Dodd J., Veale D., Fitzgerald O., Bresnihan B., Comparison of interferon γ release assays and conventional screening tests before tumour necrosis factor blockade in patients with inflammatory arthritis. Annals of the Rheumatic Diseases 2010 69 1 181 185 2-s2.0-73449099627 10.1136/ard.2008.101857
121. Matulis G., Jüni P., Villiger P. M., Gadola S. D., Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon γ assay. Annals of the Rheumatic Diseases 2008 67 1 84 90 2-s2.0-37749054451 10.1136/ard.2007.070789
122. De Leon D. P., Acevedo-Vasquez E., Alvizuri S., Gutierrez C., Cucho M., Alfaro J., Perich R., Sanchez-Torres A., Pastor C., Sanchez-Schwartz C., Medina M., Gamboa R., Ugarte M., Comparison of an interferon- γ assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. Journal of Rheumatology 2008 35 5 776 781 2-s2.0-44349124080 (Pubitemid 351747116)
123. Schoepfer A. M., Flogerzi B., Fallegger S., Schaffer T., Mueller S., Nicod L., Seibold F., Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease. American Journal of Gastroenterology 2008 103 11 2799 2806 2-s2.0-55349142845 10.1111/j.1572-0241.2008.02050.x
124. Vassilopoulos D., Stamoulis N., Hadziyannis E., Archimandritis A. J., Usefulness of enzyme-linked immunosorbent assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. Addendum. Journal of Rheumatology 2008 35 7, article 1464 2-s2.0-47349126860
125. Mazurek G. H., Jereb J., Vernon A., LoBue P., Goldberg S., Castros K., Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010. Morbidity and Mortality Weekly Report 2010 59 RR05 1 25 2-s2.0-77953994043
126. Nakaoka H., Lawson L., Squire S. B., Coulter B., Ravn P., Brock I., Hart C. A., Cuevas L. E., Risk for tuberculosis among children. Emerging Infectious Diseases 2006 12 9 1383 1388 2-s2.0-33748990337 (Pubitemid 44455214)
127. Okada K., Mao T. E., Mori T., Miura T., Sugiyama T., Yoshiyama T., Mitarai S., Onozaki I., Harada N., Saint S., Kong K. S., Chhour Y. M., Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children. Epidemiology and Infection 2008 136 9 1179 1187 2-s2.0-48249131227 10.1017/S0950268807009831
128. Petrucci R., Amer N. A., Gurgel R. Q., Sherchand J. B., Doria L., Lama C., Ravn P., Ruhwald M., Yassin M., Harper G., Cuevas L. E., Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection. Pediatric Infectious Disease Journal 2008 27 12 1073 1077 2-s2.0-58149381673 10.1097/INF.0b013e31817d05a3
129. Thomas T. A., Mondal D., Noor Z., Liu L., Alam M., Haque R., Banu S., Sun H., Peterson K. M., Malnutrition and helminth infection affect performance of an interferon γ -release assay. Pediatrics 2010 126 6 e1522 e1529 2-s2.0-78649644957 10.1542/peds.2010-0885
130. Choi J. C., Shin J. W., Kim J. Y., Park I. W., Choi B. W., Lee M. K., The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon- γ assay in the screening for latent tuberculosis infection. Chest 2008 133 6 1415 1420 2-s2.0-45949094321 10.1378/chest.07-2193 (Pubitemid 351892999)
131. Ewer K., Millington K. A., Deeks J. J., Alvarez L., Bryant G., Lalvani A., Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. American Journal of Respiratory and Critical Care Medicine 2006 174 7 831 839 2-s2.0-33749425531 10.1164/rccm.200511-1783OC (Pubitemid 44511666)
132. Hill P. C., Brookes R. H., Fox A., Jackson-Sillah D., Jeffries D. J., Lugos M. D., Donkor S. A., Adetifa I. M., De Jong B. C., Aiken A. M., Adegbola R. A., McAdam K. P., Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Medicine 2007 4 6 1061 1070 2-s2.0-34347244947 10.1371/journal.pmed.0040192 (Pubitemid 46998623)
133. Pai M., Joshi R., Dogra S., Mendiratta D. K., Narang P., Kalantri S., Reingold A. L., Colford J. M., Riley L. W., Menzies D., Serial testing of health care workers for tuberculosis using interferon- γ assay. American Journal of Respiratory and Critical Care Medicine 2006 174 3 349 355 2-s2.0-33746638695 10.1164/rccm.200604-472OC (Pubitemid 44156616)
134. van Zyl-Smit R. N., Zwerling A., Dheda K., Pai M., Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS ONE 2009 4 12 2-s2.0-76949105721 10.1371/journal.pone.0008517 e8517
135. Yoshiyama T., Harada N., Higuchi K., Nakajima Y., Ogata H., Estimation of incidence of tuberculosis infection in health-care workers using repeated interferon- γ assays. Epidemiology and Infection 2009 137 12 1691 1698 2-s2.0-70449698248 10.1017/S0950268809002751
136. Machingaidze S., Verver S., Mulenga H., Abrahams D. A., Hatherill M., Hanekom W., Predictive value of recent quantiferon conversion for tuberculosis disease in adolescents. American Journal of Respiratory and Critical Care Medicine 2012 186 10 1051 1056
137. Perry S., Sanchez L., Yang S., Agarwal Z., Hurst P., Parsonnet J., Reproducibility of QuantiFERON-TB gold in-tube assay. Clinical and Vaccine Immunology 2008 15 3 425 432 2-s2.0-42049100597 10.1128/CVI.00398-07 (Pubitemid 351967072)
138. Schablon A., Harling M., Diel R., Ringshausen F. C., Torres Costa J., Nienhaus A., Serial testing with an interferon-gamma release assay in German healthcare workers. GMS Krankenhaushygiene Interdisziplinär 2010 5 2
139. Tripodi D., Brunet-Courtois B., Nael V., Audrain M., Chailleux E., Germaud P., Naudin F., Muller J. Y., Bourrut-Lacouture M., Durand-Perdriel M. H., Gordeeff C., Guillaumin G., Houdebine M., Raffi F., Boutoille D., Biron C., Potel G., Roedlich C., Geraut C., Schablon A., Nienhaus A., Evaluation of the tuberculin skin test and the interferon-release assay for TB screening in French healthcare workers. Journal of Occupational Medicine and Toxicology 2009 4 1, article 30 2-s2.0-73849124221 10.1186/1745-6673-4-30
140. Van Brummelen S. E., Bauwens A. M., Schlösser N. J., Arend S. M., Kinetics of a tuberculosis-specific gamma interferon release assay in military personnel with a positive tuberculin skin test. Clinical and Vaccine Immunology 2010 17 6 937 943 2-s2.0-77953160856 10.1128/CVI.00005-10
141. Higuchi K., Harada N., Mori T., Interferon- γ responses after isoniazid chemotherapy for latent tuberculosis. Respirology 2008 13 3 468 472 2-s2.0-41849085514 10.1111/j.1440-1843.2008.01244.x (Pubitemid 351503140)
142. Kaplan J. E., Benson C., Holmes K. H., Brooks J. T., Pau A., Masur H., Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Morbidity and Mortality Weekly Report. Recommendations and Reports 2009 58 4 1 CE1 2-s2.0-64249152335